Sunshine Heart Review of 3Q 2016 Results and Strategic Repositioning

Loading...
Loading...

NEW YORK, NY / ACCESSWIRE / December 12, 2016 / Traders News Source, an equity research firm specializing in small and micro-cap securities, is looking at recent events with Sunshine Heart, Inc. SSH, a medical device company focused on treating moderate to severe heart problems. The company announced earnings for the third quarter of 2016 on November 8, 2016. SSH posted revenues for the first time in over a year following its acquisition of Aquadex, but EPS was still a loss.

Will investors still have a heart for Sunshine Heart after a tough 2016? Read More

Copy and paste to browser may be required- http://bit.ly/2gDhUZ3-SSH-Report

Despite the stock's recent surge, SSH remains down over -65% for 2016. The main issue is whether investors will accept (and fund) the new CEO's vision. Changes have ensued at the Company since CEO John Erb's appointment. He became permanent CEO in March of this year. His value proposition is to transform SSH to a company with lower risk, but also, potentially lower long-term upside.

Will investors still have a heart for Sunshine Heart after a tough 2016? Read the full Report

Loading...
Loading...

Copy and paste to browser may be required- http://bit.ly/2gDhUZ3-SSH-Report

Disclosure

Traders News Source LLC (TNS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. TNS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

TNS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst, for further information on analyst credentials, please email editor@tradersnewssource.com. John Vandermosten, a CFA® charter holder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written, and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author per the procedures outlined by TNS. TNS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents, or reports. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

TNS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake, or shortcoming. No liability is accepted whatsoever for any direct, indirect, or consequential loss arising from the use of this document. TNS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, TNS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness, or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TNS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever.

For any questions, inquiries, or comments reach out to us directly. If you're a company, we are covering and wish to no longer be featured on our coverage list contact us via email at:

Contact:

Email: editor@tradersnewssource.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Traders News Source

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...